Blood Screening Market by Product & Service, Technology, End-User - Global Forecast 2025-2030- Product Image

Sale

Blood Screening Market by Product & Service, Technology, End-User - Global Forecast 2025-2030

Report
188 Pages
October 2024
Region: Global
360iResearch™
ID: 5592091

UP TO €692EUR$697USD£574GBP OFF until Dec 31^st 2024

The Blood Screening Market grew from USD 4.90 billion in 2023 to USD 5.31 billion in 2024. It is expected to continue growing at a CAGR of 8.74%, reaching USD 8.82 billion by 2030.

Blood screening is a critical process in healthcare, involving the analysis of blood samples to detect infectious diseases, genetic conditions, and other health markers. This process is necessary for ensuring the safety of blood supplies, accurate diagnostics, and effective patient management. Applications of blood screening encompass transfusion safety, disease detection, personalized medicine, and epidemiological monitoring. End-users comprise hospitals, diagnostic laboratories, blood banks, and research institutions. The market is witnessing growth due to increasing awareness of blood-borne diseases, advancements in screening technologies, and rising demand for safe blood transfusions. Technological innovations such as next-generation sequencing, polymerase chain reaction (PCR), and immunoassays are key growth factors, enhancing the precision, speed, and cost-effectiveness of blood screening processes. Governments and healthcare organizations globally are emphasizing regulatory compliance and implementing stringent safety measures to ensure the efficacy of blood screening, further fueling market expansion. Emerging market opportunities include the development of point-of-care testing solutions, the integration of artificial intelligence (AI) and machine learning (ML) for predictive analytics, and the expansion of screening capabilities to address rare diseases. However, market growth is challenged by high costs associated with advanced screening technologies, regulatory complexities, and stringent approval processes, which can hinder innovation and adoption, especially in low-income regions. Furthermore, ethical concerns about genetic privacy and data security may create additional hurdles. To capitalize on growth opportunities, businesses could focus on developing cost-effective, automated screening solutions, enhancing laboratory information management systems, and collaborating with research institutions to pioneer new diagnostic tests. Areas of innovation include nanotechnology-based assays, portable diagnostic devices, and big data analytics for predictive healthcare. The blood screening market's nature is highly competitive, driven by technological advancements and regulatory landscapes. Continued investment in R&D and strategic partnerships will be crucial for businesses aiming to lead in this dynamic sector.

Understanding Market Dynamics in the Blood Screening Market

The Blood Screening Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.

Market Drivers
- Increasing demand for donated blood and rising number of blood donations
- Rising prevalence of infectious diseases and the emergence of newer pathogens
- Increase in affordability and adoption of nucleic acid test for blood screening
Market Restraints
- High price for blood screening diagnostics
Market Opportunities
- Technological Advancements in blood screening devices
- Improved POC diagnostics for blood screening
Market Challenges
- Lack of legislation, regulations, and policies on blood screening

Exploring Porter’s Five Forces for the Blood Screening Market

Porter’s Five Forces framework further strengthens the insights of the Blood Screening Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Blood Screening Market

External macro-environmental factors deeply influence the performance of the Blood Screening Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Blood Screening Market

The Blood Screening Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Blood Screening Market

The Blood Screening Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Blood Screening Market

The Blood Screening Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Blood Screening Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Alfa Scientific Designs, Inc., Becton, Dickinson And Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux SA, Danaher Corporation, DiaSorin S.p.A., Environmental & Scientific Instruments Co., F. Hoffmann-La Roche AG, GE HealthCare Technologies, Inc., GFE, Grifols, S.A., Immucor, Inc., Laboratory Corporation of America Holdings, Lifeloc Technologies, Inc, Omega Laboratories, Inc., OraSure Technologies, Inc., Ortho Clinical Diagnostics, Inc., PerkinElmer, Inc., PixCell Medical Technologies Ltd., Premier Biotech, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Trinity Biotech Plc.

Market Segmentation & Coverage

This research report categorizes the Blood Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

Product & Service
- Instruments
- Outright Purchase
- Reagents & Kits
  - ELISA Reagents & Kits
    - Conjugates
    - Controls
    - Immunosorbents
    - Sample Diluents & Wash Solutions
    - Substrates
  - NAT Reagents & Kits
    - Buffers, Nucleotides, & Solutions
    - Enzymes & Polymerases
    - Labeling & Detection Reagents
    - Probes & Primers
    - Standards & Controls
Technology
- ELISA
  - Chemiluminescent Immunoassay
  - Colorimetric Immunoassay
  - Fluorescent immunoassay
- NAT
  - Real-Time Polymerase Chain Reaction
  - Transcription-Mediated Amplification
- NGS
- Rapid Tests
- Western Blot Assays
End-User
- Blood Banks
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

What is the current size of the market, and how is it expected to grow?
Which products, segments, and regions present the most attractive investment opportunities?
What are the prevailing technology trends and regulatory factors influencing the market?
How do top vendors rank regarding market share and competitive positioning?
What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
4. Market Overview

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing demand for donated blood and rising number of blood donations
5.1.1.2. Rising prevalence of infectious diseases and the emergence of newer pathogens
5.1.1.3. Increase in affordability and adoption of nucleic acid test for blood screening
5.1.2. Restraints
5.1.2.1. High price for blood screening diagnostics
5.1.3. Opportunities
5.1.3.1. Technological Advancements in blood screening devices
5.1.3.2. Improved POC diagnostics for blood screening
5.1.4. Challenges
5.1.4.1. Lack of legislation, regulations, and policies on blood screening
5.2. Market Segmentation Analysis
5.2.1. Product: Rising adoption of instruments and consumables for conducting accurate tests
5.2.2. Technology: Development of enzyme-linked immunosorbent assay and mass spectrometry technology
5.2.3. Application: Significant applications of infectious disease and cancer screening to prevent the spread of infections
5.2.4. End-User: Increasing use of blood screening in hospitals and laboratories
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental

6. Blood Screening Market, by Product & Service

6.1. Introduction
6.2. Instruments
6.3. Outright Purchase
6.4. Reagents & Kits
6.4.1. ELISA Reagents & Kits
6.4.1.1. Conjugates
6.4.1.2. Controls
6.4.1.3. Immunosorbents
6.4.1.4. Sample Diluents & Wash Solutions
6.4.1.5. Substrates
6.4.2. NAT Reagents & Kits
6.4.2.1. Buffers, Nucleotides, & Solutions
6.4.2.2. Enzymes & Polymerases
6.4.2.3. Labeling & Detection Reagents
6.4.2.4. Probes & Primers
6.4.2.5. Standards & Controls

7. Blood Screening Market, by Technology

7.1. Introduction
7.2. ELISA
7.2.1. Chemiluminescent Immunoassay
7.2.2. Colorimetric Immunoassay
7.2.3. Fluorescent immunoassay
7.3. NAT
7.3.1. Real-Time Polymerase Chain Reaction
7.3.2. Transcription-Mediated Amplification
7.4. NGS
7.5. Rapid Tests
7.6. Western Blot Assays

8. Blood Screening Market, by End-User

8.1. Introduction
8.2. Blood Banks
8.3. Hospitals

9. Americas Blood Screening Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Blood Screening Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Blood Screening Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Harbinger Health Raises $140M to Study Blood-Based Cancer Screening Test
12.3.2. Oxford Biodynamics Announces US Launch of its 94% Accurate EpiSwitch Prostate Screening Blood Test to Men With Prostate Cancer Risk
12.3.3. Walgreens and Freenome to Advance Blood-Based Test Trials For Cancer
12.4. Strategy Analysis & Recommendation

List of Figures

FIGURE 1. BLOOD SCREENING MARKET RESEARCH PROCESS
FIGURE 2. BLOOD SCREENING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BLOOD SCREENING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BLOOD SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

List of Tables

TABLE 1. BLOOD SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BLOOD SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BLOOD SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BLOOD SCREENING MARKET DYNAMICS
TABLE 7. GLOBAL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BLOOD SCREENING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BLOOD SCREENING MARKET SIZE, BY OUTRIGHT PURCHASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BLOOD SCREENING MARKET SIZE, BY CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BLOOD SCREENING MARKET SIZE, BY IMMUNOSORBENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BLOOD SCREENING MARKET SIZE, BY SAMPLE DILUENTS & WASH SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BLOOD SCREENING MARKET SIZE, BY SUBSTRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BLOOD SCREENING MARKET SIZE, BY BUFFERS, NUCLEOTIDES, & SOLUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BLOOD SCREENING MARKET SIZE, BY ENZYMES & POLYMERASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BLOOD SCREENING MARKET SIZE, BY LABELING & DETECTION REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL BLOOD SCREENING MARKET SIZE, BY PROBES & PRIMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL BLOOD SCREENING MARKET SIZE, BY STANDARDS & CONTROLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL BLOOD SCREENING MARKET SIZE, BY CHEMILUMINESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL BLOOD SCREENING MARKET SIZE, BY COLORIMETRIC IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL BLOOD SCREENING MARKET SIZE, BY FLUORESCENT IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL BLOOD SCREENING MARKET SIZE, BY REAL-TIME POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL BLOOD SCREENING MARKET SIZE, BY TRANSCRIPTION-MEDIATED AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL BLOOD SCREENING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL BLOOD SCREENING MARKET SIZE, BY RAPID TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL BLOOD SCREENING MARKET SIZE, BY WESTERN BLOT ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL BLOOD SCREENING MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL BLOOD SCREENING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 51. ARGENTINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 52. ARGENTINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 53. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 66. BRAZIL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. CANADA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 68. CANADA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 69. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 70. CANADA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 71. CANADA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. CANADA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 73. CANADA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 74. CANADA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. MEXICO BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 76. MEXICO BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 77. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 78. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. MEXICO BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 81. MEXICO BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 82. MEXICO BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 83. UNITED STATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 84. UNITED STATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 85. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES BLOOD SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 92. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 93. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 94. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 95. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 96. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 98. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 99. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. ASIA-PACIFIC BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 101. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 102. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 103. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 104. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 105. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 106. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 107. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 108. AUSTRALIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 109. CHINA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 110. CHINA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 111. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 112. CHINA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 113. CHINA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 114. CHINA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 115. CHINA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 116. CHINA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 117. INDIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 118. INDIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 119. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 120. INDIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 121. INDIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. INDIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 123. INDIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 124. INDIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. INDONESIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 126. INDONESIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 127. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 128. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 129. INDONESIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 130. INDONESIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 131. INDONESIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 132. INDONESIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 133. JAPAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 134. JAPAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 135. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 136. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 137. JAPAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 138. JAPAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 139. JAPAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 140. JAPAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. MALAYSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 142. MALAYSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 143. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 144. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 145. MALAYSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. MALAYSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 147. MALAYSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 148. MALAYSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 150. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 151. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 152. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 153. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 154. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 155. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 156. PHILIPPINES BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 157. SINGAPORE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 158. SINGAPORE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 159. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 160. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 161. SINGAPORE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. SINGAPORE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 163. SINGAPORE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 164. SINGAPORE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 166. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 168. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 169. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 171. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 172. SOUTH KOREA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. TAIWAN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 174. TAIWAN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 175. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 176. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 177. TAIWAN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 178. TAIWAN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 179. TAIWAN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 180. TAIWAN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. THAILAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 182. THAILAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 183. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 184. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 185. THAILAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 186. THAILAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 187. THAILAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 188. THAILAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 189. VIETNAM BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 190. VIETNAM BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 191. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 192. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 193. VIETNAM BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. VIETNAM BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 195. VIETNAM BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 196. VIETNAM BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA BLOOD SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 206. DENMARK BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 207. DENMARK BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 208. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 209. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. DENMARK BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 212. DENMARK BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 213. DENMARK BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 214. EGYPT BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 216. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 217. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 218. EGYPT BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 220. EGYPT BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 221. EGYPT BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 222. FINLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 223. FINLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 224. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 225. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 226. FINLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. FINLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 228. FINLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 229. FINLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 230. FRANCE BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 231. FRANCE BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 232. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 233. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. FRANCE BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 236. FRANCE BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 237. FRANCE BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. GERMANY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 239. GERMANY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 241. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 242. GERMANY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. GERMANY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 244. GERMANY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 245. GERMANY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 247. ISRAEL BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 248. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 249. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 250. ISRAEL BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. ISRAEL BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 252. ISRAEL BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 253. ISRAEL BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 254. ITALY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 255. ITALY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 256. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 257. ITALY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 258. ITALY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. ITALY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 260. ITALY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 261. ITALY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 263. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 264. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 265. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 266. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 268. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 269. NETHERLANDS BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 270. NIGERIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 271. NIGERIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 272. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 273. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 274. NIGERIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. NIGERIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 276. NIGERIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 277. NIGERIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 278. NORWAY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 279. NORWAY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 280. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 281. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 282. NORWAY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 283. NORWAY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 284. NORWAY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 285. NORWAY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 286. POLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 287. POLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 288. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 289. POLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 290. POLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 291. POLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 292. POLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 293. POLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 294. QATAR BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 295. QATAR BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 296. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 297. QATAR BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 298. QATAR BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 299. QATAR BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 300. QATAR BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 301. QATAR BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 302. RUSSIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 303. RUSSIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 304. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 305. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 306. RUSSIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 307. RUSSIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 308. RUSSIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 309. RUSSIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 311. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 312. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 313. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 314. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 315. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 316. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 317. SAUDI ARABIA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 318. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 319. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 320. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 321. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 322. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 323. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 324. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 325. SOUTH AFRICA BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 326. SPAIN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 327. SPAIN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 328. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 329. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 330. SPAIN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 331. SPAIN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 332. SPAIN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 333. SPAIN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 334. SWEDEN BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 335. SWEDEN BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 336. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 337. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 338. SWEDEN BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 339. SWEDEN BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 340. SWEDEN BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 341. SWEDEN BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 342. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 343. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 344. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 345. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 346. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 347. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 348. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 349. SWITZERLAND BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 350. TURKEY BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 351. TURKEY BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 352. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 353. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 354. TURKEY BLOOD SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 355. TURKEY BLOOD SCREENING MARKET SIZE, BY ELISA, 2018-2030 (USD MILLION)
TABLE 356. TURKEY BLOOD SCREENING MARKET SIZE, BY NAT, 2018-2030 (USD MILLION)
TABLE 357. TURKEY BLOOD SCREENING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 358. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 359. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 360. UNITED ARAB EMIRATES BLOOD SCREENING MARKET SIZE, BY ELISA REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 361. UNITED ARAB EMIRATES BLOOD SCREENING MARKE

Companies Mentioned

The leading players in the Blood Screening Market, which are profiled in this report, include:

Abbott Laboratories
Alfa Scientific Designs, Inc.
Becton, Dickinson And Company
Bio-Rad Laboratories, Inc.
Bio-Techne Corporation
bioMérieux SA
Danaher Corporation
DiaSorin S.p.A.
Environmental & Scientific Instruments Co.
F. Hoffmann-La Roche AG
GE HealthCare Technologies, Inc.
GFE
Grifols, S.A.
Immucor, Inc.
Laboratory Corporation of America Holdings
Lifeloc Technologies, Inc
Omega Laboratories, Inc.
OraSure Technologies, Inc.
Ortho Clinical Diagnostics, Inc.
PerkinElmer, Inc.
PixCell Medical Technologies Ltd.
Premier Biotech, Inc.
Siemens Healthineers AG
Thermo Fisher Scientific Inc.
Trinity Biotech Plc

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	188
Published	October 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 5.31 Billion
Forecasted Market Value ( USD ) by 2030	$ 8.82 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	26

License	Format	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access		This is a single user license, allowing one user access to the product.	€3518EUR$3,545USD£2,919GBP €3909EUR$3,939USD£3,243GBP
ENTERPRISE LICENSE PDF, Excel and Online Access		This is an enterprise license, allowing all employees within your organization access to the product.	€6224EUR$6,272USD£5,164GBP €6915EUR$6,969USD£5,738GBP

Understanding Market Dynamics in the Blood Screening Market

Exploring Porter’s Five Forces for the Blood Screening Market

Applying PESTLE Analysis to the Blood Screening Market

Analyzing Market Share in the Blood Screening Market

Evaluating Vendor Success with the FPNV Positioning Matrix in the Blood Screening Market

Strategic Recommendations for Success in the Blood Screening Market

Key Company Profiles

Market Segmentation & Coverage

The report provides a detailed overview of the market, exploring several key areas:

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Blood Screening Market Size, Share & Trends Analysis Report by Technology (Nucleic Acid Amplification Test, ELISA, Western Blotting), Product (Reagent, Instrument), Region, and Segment Forecasts, 2025-2030

Blood Screening - Global Strategic Business Report

Blood Screening Global Market Report 2024

Blood Screening - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

Blood Screening Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

About the Blood Screening Market